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Abstract
The amiloride-inhibitable Na/H antiporter plays an important role in macrophage activation. The intracellular
pathways leading to interleukin (IL)-12 p40 production by activated macrophages are incompletely understood. In the
present study, we examined the contribution of the Na/H antiporter to the production of IL-12 p40. Amiloride or its
analogs decreased the production of IL-12 p40 in macrophages stimulated with bacterial lipopolysaccharide and interferon-Q.
The order of potency of amiloride analogs was consistent with the proposition that the effect of amiloride is mediated by the
inhibition of the Na/H antiporter. The effect of amiloride was post-transcriptional, as IL-12 p40 mRNA levels induced by
lipopolysaccharide and interferon-Q were not affected by this inhibitor. Furthermore, the inhibitory effect of amiloride on IL-
12 p40 production was not a result of interference with the activation of the p38 and p42/44 mitogen-activated protein
kinases or c-Jun kinase. In summary, the production of IL-12 p40 requires a functional Na/H antiporter. ß 2001
Elsevier Science B.V. All rights reserved.
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1. Introduction
Interleukin (IL)-12 is a heterodimeric cytokine that
is secreted mainly by activated antigen-presenting
cells and plays a key role in determining the nature
of the immune response to exogenous or endogenous
antigens. IL-12 is comprised of two disul¢de-linked
protein subunits designated p35 and p40 [1,2]. Both
subunits have to be produced within the same cell to
obtain the biologically active dimer, designated p70.
Although the production of p40 exceeds the produc-
tion of p70 by from 40-fold to more than 500-fold
depending on the experimental system [3^5], changes
in p40 levels by pharmacological interventions are
closely followed by similar changes in the levels of
p70 [6^12]. The main producers of IL-12 are the cells
of the monocyte/macrophage lineage including
monocytes [13], macrophages [14], Kup¡er cells
[15], mesangial cells [16], dendritic cells [1,2], and
glial cells [17].
The main targets of IL-12 are T lymphocytes and
natural killer (NK) cells [1]. IL-12 activates interfer-
on (IFN)-Q production, proliferation, and cytolytic
activity of NK cells and T lymphocytes [1]. In turn,
IFN-Q promotes IL-12 production and macrophage
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activation, which provides the basis of an autoregu-
latory positive feedback loop resulting in a strong
immune/in£ammatory response directed against the
antigen. Early in the immune response, IL-12 also
plays a critical role in directing the development of
T helper (Th)1 versus Th2 cell di¡erentiation charac-
terized by an increased production of IFN-Q and IL-2
(Th1 cytokines) and suppression of IL-4, IL-5 and
IL-10 (Th2 cytokines) formation [1]. While an IL-12-
induced Th1 response is critical for the removal of
intracellular pathogens such as certain bacteria and
viruses, overproduction of this cytokine is involved
in the induction of the pathophysiology of several
autoimmune diseases. These include multiple sclero-
sis [18], in£ammatory bowel disease [19], insulin de-
pendent diabetes mellitus [20], and rheumatoid ar-
thritis [21]. The overproduction of IL-12 is also an
important pathogenic factor in in£ammatory states
such as septic shock [3] and the generalized Shwartz-
man reaction [22].
Na/H antiporters are vital transmembrane
transporters involved in multiple cellular functions
including regulation of intracellular Na levels, ad-
justment of intracellular pH, control of cell volume,
and mitogenesis [23]. Recently, it has been shown
that these transporters play an important role in
the regulation of monocyte/macrophage functions.
A variety of stimuli, including lipopolysaccharide
(LPS) [24], tumor necrosis factor (TNF)-K [24], and
IFN-Q [25], that induce the activation of monocyte/
macrophages also stimulate the function of the Na/
H antiporter. The increased activity of the Na/H
exchanger importantly contributes to the promotion
of several macrophage functions, including cytokine
production [26^28], prostaglandin release [29], upreg-
ulation of Ia expression [25], FcQ receptor expression
[30], and CSF-1-induced proliferation [31].
Because of the crucial role of IL-12 in orchestrat-
ing the immune response, it is important to identify
endogenous mechanisms and pathways that regulate
the production of this cytokine [12]. Based on the
evidence discussed above, we hypothesized that the
Na/H exchanger may play an important role in
the regulation of the production of IL-12. Our data
show that blockade of the activation of the Na/H
exchanger suppresses IL-12 production suggesting
that this exchanger is an important component of
the cellular machinery that produces IL-12.
2. Materials and methods
2.1. Drugs and reagents
Amiloride HCl, 5-(N-methyl-N-isobutyl)-amiloride
(MIA), 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), 5-
(N,N-dimethyl)-amiloride (DMA), and benzamil HCl
were obtained from Research Biochemicals Inc (Na-
tick, MA). LPS (Escherichia coli 055:B5) was pur-
chased from Sigma (St. Louis, MO). 3-(4,5-di-
methylthiazol-2-yl)-2,5-Diphenyltetrazolium bromide
(MTT) was obtained from Fisher Scienti¢c (Pitts-
burgh, PA).
2.2. Preparation and treatment of peritoneal
macrophages
Male BALB/c mice (Charles River, Boston, MA)
were injected intraperitoneally with 2 ml of 2% thio-
glycollate and peritoneal cells were harvested 3^4
days later. The cells were plated on 96-well plastic
plates at 1 million cells/ml and incubated in RPMI
1640 (Life Technologies (Grand Island, NY) for 2 h
at 37‡C in a humidi¢ed 5% CO2 incubator. Non-
adherent cells were removed by rinsing the plates
three times with 5% dextrose in phosphate-bu¡ered
saline. Cells were treated with various concentrations
of amiloride 30 min before the addition of a combi-
nation of LPS (10 Wg/ml) and IFN-Q (100 U/ml) for
an additional 24 h. IL-12 was measured from super-
natants taken 24 h after the addition of LPS. IL-12
levels were determined by enzyme-linked immuno-
sorbent assay (ELISA) as described below.
2.3. Culture and treatment of J774 macrophages
The mouse macrophage cell line J774.1 was grown
in RPMI 1640 supplemented with 10% FBS, 100 U/
ml penicillin, and 100 Wg/ml streptomycin in a hu-
midi¢ed atmosphere of 95% air and 5% CO2. Cells
were cultured in 96-well plates (200 Wl medium per
well) until 80% con£uence. For cytokine assays, the
cells were pretreated with various concentrations of
amiloride or its analogs 30 min before stimulation
with a combination of LPS and IFN-Q (100 U/ml).
Supernatants for cytokine determination were ob-
tained 3 h (for macrophage in£ammatory protein
(MIP)-1K and MIP-2 measurement) or 24 h (for
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IL-12 p40 determination) after stimulation with LPS/
IFN-Q. Amiloride or its analogs were present in the
cells throughout the experiment.
2.4. Cytokine assays
Cytokine concentrations in the supernatants were
determined by ELISA kits that are speci¢c for mur-
ine cytokines. Levels of IL-12 p40, MIP-1K, and
MIP-2 were measured using ELISA kits purchased
from Genzyme Co. (Boston, MA). Plates were read
at 450 nm by a Spectramax 250 microplate reader
from Molecular Devices (Sunnyvale, CA). Detection
limits were10 pg/ml for IL-12 (p40), 1.5 pg/ml for
MIP-1K, and 1.5 pg/ml for MIP-2. Assays were per-
formed as described previously [32] and according to
the manufacturer’s instructions.
2.5. Western blot analysis
J774 cells in 6-well plates were pretreated with
amiloride (300 WM) or vehicle (10% dimethylsulfox-
ide) and 30 min later the cells were stimulated with
LPS/IFN-Q for 15 min. After washing with phos-
phate-bu¡ered saline, the cells were lysed by the ad-
dition of modi¢ed radioimmunoprecipitation (RIPA)
bu¡er (50 mM Tris^HCl, 150 mM NaCl, 1 mM
EDTA, 0.25% Na-deoxycholate, 1% NP-40, 1 Wg/
ml pepstatin, 1 Wg/ml leupeptin, 1 mM PMSF,
1 mM Na3VO4). The lysates were transferred to
Eppendorf tubes, centrifuged at 15 000Ug and the
supernatant was recovered. Protein concentrations
were determined using a Bio-Rad Protein Assay
(Bio-Rad, Hercules, CA). Ten Wg of sample was sep-
arated on a 8^16% Tris-Glycine gel (Novex, San Die-
go, CA) and transferred to a nitrocellulose mem-
brane. The membranes were probed with anti-
phospho-mitogen-activated protein kinase (MAPK;
p42/p44), anti-phospho-c-Jun N-terminal protein ki-
nase (JNK, Promega, Madison, WI), anti-phospho-
p38 MAP kinase (p38 MAPK, New England Bio-
labs, Beverly, MA) and subsequently incubated
with a secondary horseradish peroxidase-conjugated
donkey anti-rabbit antibody (Boehringer Mannheim,
Indianapolis, IN). Bands were detected using ECL
Western Blotting Detection Reagent (Amersham
Life Science, Arlington Heights, IL).
2.6. RNA isolation and reverse transcriptase^
polymerase chain reaction (RT^PCR)
Total RNA was isolated from J774 cells using
TRIzol Reagent (Life Technologies, Grand Island,
NY). Reverse transcription of the RNA was per-
formed using MuLV reverse transcriptase from Per-
kin Elmer (50 U/Wl, Foster City, CA). Five Wg of
RNA was transcribed in a 20-Wl reaction containing
10.7 ml RNA, 2 Wl 10UPCR bu¡er, 2 Wl 10 mM
dNTP mix, 2 Wl 25 mM MgCl2, 2 Wl 100 mM
DTT, 0.5 Wl RNase inhibitor (Perkin, 20 U/Wl), 0.5
Wl 50 mM oligo d(T)16, and 0.3 ml reverse transcrip-
tase. The reaction mix was incubated at 42‡C for 15
min for reverse transcription. Thereafter, the reverse
transcriptase was inactivated at 99‡C for 5 min. RT-
generated DNA (1^5 Wl) was ampli¢ed using Expand
High Fidelity PCR System (Boehringer Mannheim).
The reaction bu¡er (25 Wl) contained 1^5 Wl cDNA,
water, 2.5 Wl PCR bu¡er, 1.5 Wl 25 mM MgCl2, 1Wl
10 mM dNTP mix, 0.5 Wl 10 mM oligonucleotide
primer (each), and 0.2 Wl enzyme. cDNA was ampli-
¢ed using the following primers and conditions: IL-
12 p40 [33] 5P-ATGTGTCCTCAGAAGCTAACC-3P
(sense) and 5P-GGTCCAGTGTGACCTTCTCTGC-
3P and L-actin-5P-GAGACCTTCAACACCC-3P
(sense) and 5P-GTGGTGGTGAAGCTGTAGCC-3P
(anti-sense), an initial denaturation at 94‡CU5 min,
27 and 24 cycles of 94‡CU30 s, 58‡CU45 s,
72‡CU45 s for IL-12 p40 and L-actin, respectively;
a ¢nal dwell at 72‡CU7 min. The expected PCR
products were IL-12 p40 510 bp and L-actin 230
bp. PCR products were resolved on a 1.5% agarose
gel and stained with ethidium bromide.
2.7. Measurement of mitochondrial respiration
Mitochondrial respiration, an indicator of cell vi-
ability, was assessed by the mitochondria-dependent
reduction of MTT to formazan [34]. Cells in 96-well
plates were incubated with MTT (0.5 mg/ml) for 60
min at 37‡C. Culture medium was removed by aspi-
ration, and the cells were solubilized in dimethylsulf-
oxide (100 Wl). The extent of reduction of MTT to
formazan within cells was quantitated by measure-
ment of optical density at 550 nm (OD550) using a
Spectramax 250 microplate reader.
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2.8. Protein synthesis assay
J774 cell de novo protein synthesis was determined
as incorporation of 3H-amino acids into newly syn-
thesized, perchloric acid (PCA) precipitable protein.
J774 cells were treated with the various concentra-
tions of amiloride in media containing a mixture of
3H-amino acids (Amersham, 100 000 dpm well31) for
24 h. Following treatment, the medium was removed
and the cellular protein precipitated by adding 800 Wl
ice-cold 5% PCA to each well and leaving the plate
on ice for 30 min. The PCA was then removed and
the protein solubilized in 200 Wl sodium hydroxide
(0.1 M) for 30 min at room temperature. 3H-amino
Fig. 1. Amiloride (A) and the amiloride analogs EIPA, DMA, MIA, and benzamil (B,C) decrease IL-12 p40 production by J774 mac-
rophages stimulated with the combination of LPS (10 Wg/ml) and IFN-Q (100 U/ml). Amiloride also inhibits the production of IL-12
p40 by peritoneal cells induced with the combination of LPS and IFN-Q (E). Amiloride does not alter cellular viability in the J774
cells as tested with the MTT assay (D). Macrophages were pretreated with amiloride or the amiloride analogs 30 min before stimula-
tion with LPS and IFN-Q. IL-12 p40 was measured from the supernatants 24 h after stimulation. Data are expressed as the mean þ
S.E.M. of six wells. *P6 0.05; **P6 0.01.
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acid incorporation into protein was measured by liq-
uid scintillation counting and results expressed as a
percentage of the dpm obtained from untreated cells.
2.9. In vivo studies
Mice were injected i.p. with drug vehicle (100%
DMSO) or amiloride (12.5 mg/kg) in a volume of
0.1 ml/10 g body weight. Thirty minutes later, they
were challenged with 5 mg/kg of LPS administered
i.p. The animals were bled at 90 min after LPS treat-
ment. Blood was collected in ice-cold Eppendorf
tubes containing heparin and centrifuged for 10
min at 4‡C. The plasma was stored at 370‡C until
assayed. IL-12 p40 from the plasma was detected
with ELISA as described above.
2.10. Statistical evaluation
Values in the ¢gures and text are expressed as
mean þ S.E.M. of n observations. Statistical analysis
of the data was performed by one-way analysis of
variance followed by Dunnett’s test, as appropriate.
3. Results
3.1. E¡ect of amiloride, MIA, DMA, EIPA, and
benzamil, on IL-12 p40, MIP-1a and MIP-2
production in J774 macrophages and peritoneal
macrophages
The combined administration of LPS (10 Wg/ml)
and IFN-Q (100 U/ml) to J774 cells for 24 h caused
the appearance of IL-12 p40 in the culture superna-
tants. Pretreatment of the cells with amiloride, MIA,
DMA, EIPA, and benzamil 30 min before stimula-
tion suppressed IL-12 p40 production in a dose-de-
pendent manner (Fig. 1A^C). The order of potency
of drugs was EIPAsMIAsDMAs amilorides
benzamil (Fig. 1A^C). Neither amiloride (Fig. 1D)
nor the amiloride analogs (data not shown) were
toxic to the cells, as determined by the MTT assay.
To investigate whether amiloride suppresses the
production of other cytokines, we assessed the e¡ect
of amiloride on the production of the chemokines
MIP-1K and MIP-2. LPS treatment of the J774 cells
caused the appearance of both MIP-1K and MIP-2
3 h after stimulation (Fig. 2A,B). Amiloride pretreat-
ment of the cells 30 min before the LPS challenge
inhibited the production of both MIP-1K and MIP-2,
both in a concentration-dependent manner (Fig.
2A,B).
To investigate the possibility that amiloride ex-
erted its e¡ect via a non-speci¢c suppression of gen-
eral protein synthesis, we determined whether ami-
loride a¡ects de novo protein biosynthesis over a 24-
h period utilizing the 3H-amino acid incorporation
method. Fig. 3 demonstrates that amiloride failed
to decrease protein synthesis up to 100 WM; however,
it caused a slight decrease of 3H-amino acid incorpo-
ration at 300 WM (by about 15%). Therefore, since
amiloride caused a signi¢cant inhibition of IL-12
p40, as well as MIP-1K and MIP-2 production even
at 100 WM concentration, it can be concluded that
the e¡ect of amiloride at 100 WM or less is not due to
Fig. 2. Amiloride inhibits the production of the chemokines MIP-1K (A) and MIP-2 (B) by J774 macrophages. The macrophages were
pretreated with amiloride 30 min before stimulation with LPS (10 Wg/ml). Chemokines were measured from the supernatants taken 3 h
after the stimulation. Data are expressed as the mean þ S.E.M. of six wells. *P6 0.05; **P6 0.01.
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a non-speci¢c e¡ect on protein synthesis. This idea is
supported by the fact that while at 300 WM, amilor-
ide suppressed IL-12 p40 and chemokine production
by 50^70%, the extent of inhibition on protein syn-
thesis was only 15%.
We next investigated whether the e¡ect of amilor-
ide can be reproduced using primary cells. Fig. 1E
shows that amiloride suppresses the production of
IL-12 p40 in freshly harvested peritoneal macro-
phages. Amiloride was not toxic in these cells as
determined using the MTT assay (data not shown).
3.2. Amiloride suppresses IL-12 p40 production by a
post-transcriptional mechanism
Using semi-quantitative RT^PCR, we determined
that treatment of J774 macrophages with LPS (10
Wg/ml) and IFN-Q (100 U/ml) induces the appearance
of mRNA for IL-12 p40, as measured 4 h after stim-
ulation (Fig. 4). However, pretreatment of the cells
with amiloride (300 WM) 30 min before stimulation,
failed to alter the levels of p40 mRNA (Fig. 4A).
Therefore, it appears that the e¡ect of amiloride on
IL-12 p40 production is post-transcriptional.
3.3. Amiloride fails to alter the LPS-induced
activation of the p38 and p42/44 MAPKs,
or the phosphorylation of JNK
Because activation of the MAPKs p38 and p42/44
and the phosphorylation of JNK are important path-
ways during macrophage activation [35,36], we tested
the possibility that amiloride exerts its e¡ects on IL-
12 p40 production via interfering with the activation
of these enzymes. Although LPS/IFN-Q treatment of
peritoneal macrophages caused the activation of
both p38 and p42/44 as well as JNK determined 15
min after LPS/IFN-Q treatment, amiloride adminis-
tered 30 min before the LPS/IFN-Q challenge failed
to alter the activation of these intracellular pathways
(Fig. 4B).
Fig. 4. (A) Lack of e¡ect of amiloride (300 WM) on steady-state
levels of IL-12 p40 mRNA in J774 macrophages induced by
LPS/IFN-Q. L-Actin levels were not a¡ected by both LPS and
amiloride treatment. The macrophages were pretreated with
amiloride for 30 min, followed by an LPS treatment for 4 h.
Lanes 1 and 2, control; lanes 3 and 4, LPS/IFN-Q ; lanes 5 and
6, amiloride+LPS/IFN-Q. Cytokine mRNA levels were quanti-
tated using semi-quantitative RT^PCR. This ¢gure is represen-
tative of ¢ve separate experiments. (B) Amiloride fails to a¡ect
both p38 and p44 MAP kinase, as well as JNK activation
stimulated with LPS/IFN-Q in J774 macrophages. Cells were
pretreated with amiloride (300 WM) for 30 min followed by
LPS/IFN-Q challenge for 15 min. MAPK and JNK activation
(phosphorylation) was determined using Western blotting.
Lanes 1 and 2, control; lanes 3 and 4, LPS/IFN-Q ; lanes 5 and
6, amiloride+LPS/IFN-Q. This ¢gure is representative of two
separate experiments.
Fig. 3. E¡ect of amiloride on de novo protein synthesis in J774
cells. J774 cells were treated with various concentrations of ami-
loride for 24 h and protein synthesis was determined as de-
scribed in Section 2. Data are expressed as the mean þ S.E.M.
of six wells. *P6 0.05.
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3.4. Amiloride inhibits IL-12 p40 production in vivo
To assess the e¡ect of amiloride in vivo, we uti-
lized an endotoxemic mouse model, in which IL-12
p40 production was induced by intraperitoneal LPS
(5 mg/kg) injection. IL-12 levels were measured from
the plasma of the animals 4h after LPS injection.
Under these conditions, amiloride (12.5 mg/kg) pre-
treatment of the animals 30 min before the LPS in-
jection signi¢cantly suppressed the plasma IL-12 lev-
el induced by LPS (Fig. 5).
4. Discussion
The movement of ions across cell membranes me-
diates several cellular processes in the immune sys-
tem. There is a large body of evidence indicating that
the alteration of the activity of ion channels and
pumps profoundly a¡ects cytokine production [37^
39]. IL-12 production is also subject to modulation
by changes in ion movements. Blockade of dihydro-
pyridine-sensitive calcium channels inhibits IL-12
production in human dendritic cells, which can be
prevented by a calcium channel agonist [40]. These
channels are also the molecular targets of HIV Tat,
which blocks both calcium in£ux and IL-12 release in
the dendritic cells. This mechanism may contribute
to the immunosuppression seen during HIV infec-
tion. In LPS-treated mice, the calcium channel antag-
onists verapamil and diltiazem are unable to suppress
plasma IL-12 levels; however, dantrolene, an agent
known to prevent the release of calcium from its
intracellular stores, inhibits IL-12 production [41].
The present study demonstrates that inhibition of
the Na/H exchanger with amiloride or amiloride
analogs suppresses the production of IL-12 p40 by
macrophages. Although amiloride is a relatively se-
lective inhibitor of the Na/H exchanger, it has
e¡ects on a number of other systems, including
Na channels and the Na/Ca exchanger [42].
Our data, however, demonstrated that EIPA, MIA,
and DMA, selective inhibitors of the Na/H ex-
changer [43] were more potent than the non-selective
amiloride or benzamil, which is a relatively selective
inhibitor of the Na/Ca exchanger [42]. Therefore,
the most feasible interpretation of the current data is
that the inhibitory e¡ect of amiloride on IL-12 pro-
duction is mediated through the Na/H antiporter.
The Na/H antiporter appears to play an important
role in the promotion of cytokine production by the
monocyte/macrophage lineage. Inhibition of the
Na/H antiporter has been shown to suppress the
production of TNF-K [26,28], IL-1 [44], IL-6 [26],
and IL-8 [26]. While the activation of the Na/H
antiporter augments both TNF-K and IL-1 produc-
tion, both of these cytokines stimulate the Na/H
antiporter [24,45], Therefore, it can be suggested that
TNF-K and IL-1, and the Na/H antiporter are
parts of an autoregulatory feedback loop, which is
involved in the ampli¢cation of macrophage activa-
tion. However, it remains to be determined whether
IL-12 is also involved in this autoregulatory cycle.
Interestingly, while the e¡ect of amiloride on
TNF-K, IL-6, and IL-8 production by human alveo-
lar monocytes is transcriptional [26], the mechanism
of action of amiloride’s suppressive e¡ect on IL-12
production in the J774 macrophages is post-tran-
scriptional. The LPS/IFN-Q-induced activation of
the MAPKs p38 and p42/44, and JNK are important
pathways that can modulate cytokine production at
post-transcriptional steps [36,46]. Because amiloride
has been demonstrated to regulate these stress ki-
nases [47], we evaluated whether the amiloride sup-
pression of IL-12 production could be explained by
an e¡ect on these pathways. Our results showed that
the LPS-induced activation of none of these enzymes
is altered by amiloride. Similar to our observation
Fig. 5. Amiloride inhibits IL-12 p40 production in vivo. Male
BALB/c mice were pretreated with amiloride (12.5 mg/kg; i.p.)
30 min before i.p. injection of 5 mg/kg of LPS. IL-12 p40 con-
centrations were determined from the plasma taken 4 h after
the LPS injection. Data are mean þ S.E.M. of n = 8 mice.
*P6 0.05.
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with LPS/IFN-Q-stimulated stress kinase activation,
stress kinase activation induced by hyperosmolarity-
induced cytosolic alkalinization is una¡ected by inhi-
bition of the Na/H antiporter [48].
It is important to note that the e¡ect of amiloride
was reproduced in vivo: amiloride at 12.5 mg/kg sup-
pressed IL-12 p40 plasma levels induced by LPS.
This dose of amiloride was selected based on a pre-
vious study [49]. The ¢nding that amiloride inhibits
IL-12 p40 production in vivo suggests that inhibition
of the Na/H antiporter may be a therapeutic ap-
proach in IL-12 mediated in£ammatory/autoimmune
diseases, such as rheumatoid arthritis, in£ammatory
bowel disease or insulin-dependent diabetes.
Finally, we also show that blockade of the Na/
H exchanger inhibits the production of the chemo-
kines MIP-1K and MIP-2. These data demonstrate
that the e¡ect of amiloride on IL-12 p40 is not se-
lective and further con¢rm the notion that the acti-
vation of the Na/H exchanger has a general proin-
£ammatory role.
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